K
Klaviyo Inc
NYSE:KVYO
Klaviyo Inc
NYSE:KVYO
Price:
20.63
USD
2.84%
Market Cap:
$6.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Klaviyo Inc
NYSE:KVYO
|
US |
|
A
|
Apontis Pharma AG
XETRA:APPH
|
DE |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
IN |
|
Amrutanjan Health Care Ltd
NSE:AMRUTANJAN
|
IN |
|
Zhuzhou Smelter Group Co Ltd
SSE:600961
|
CN |
|
R
|
Raba Jarmuipari Holding Nyrt
BET:RABA
|
HU |
|
Kontrolmatik Teknoloji Enerji ve Muhendislik AS
IST:KONTR.E
|
TR |
Balance Sheet
Balance Sheet Decomposition
Klaviyo Inc
Klaviyo Inc
Balance Sheet Decomposition is not available for
Klaviyo Inc
Klaviyo Inc
Balance Sheet
Klaviyo Inc
Klaviyo Inc
Currency: USD
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
328
|
386
|
739
|
881
|
1 065
|
|
| Cash Equivalents |
328
|
386
|
739
|
881
|
1 065
|
|
| Total Receivables |
6
|
11
|
23
|
43
|
61
|
|
| Accounts Receivables |
6
|
11
|
23
|
43
|
61
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
22
|
31
|
42
|
55
|
80
|
|
| Total Current Assets |
356
|
428
|
803
|
980
|
1 206
|
|
| PP&E Net |
90
|
92
|
80
|
91
|
181
|
|
| PP&E Gross |
90
|
92
|
80
|
91
|
181
|
|
| Accumulated Depreciation |
7
|
15
|
29
|
45
|
62
|
|
| Other Long-Term Assets |
19
|
110
|
205
|
202
|
193
|
|
| Total Assets |
464
N/A
|
629
+35%
|
1 089
+73%
|
1 273
+17%
|
1 581
+24%
|
|
| Liabilities | ||||||
| Accounts Payable |
32
|
9
|
14
|
15
|
29
|
|
| Accrued Liabilities |
30
|
51
|
77
|
121
|
150
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
15
|
25
|
40
|
64
|
103
|
|
| Total Current Liabilities |
77
|
85
|
131
|
200
|
282
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
57
|
48
|
44
|
39
|
102
|
|
| Total Liabilities |
134
N/A
|
133
-1%
|
174
+31%
|
239
+37%
|
384
+60%
|
|
| Equity | ||||||
| Common Stock |
2 567
|
1 532
|
0
|
0
|
0
|
|
| Retained Earnings |
2 236
|
2 285
|
799
|
845
|
877
|
|
| Additional Paid In Capital |
0
|
1 249
|
1 714
|
1 879
|
2 073
|
|
| Total Equity |
330
N/A
|
496
+50%
|
915
+85%
|
1 034
+13%
|
1 197
+16%
|
|
| Total Liabilities & Equity |
464
N/A
|
629
+35%
|
1 089
+73%
|
1 273
+17%
|
1 581
+24%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
252
|
252
|
259
|
273
|
304
|
|
Switch to:
Switch to:
See Also
Discover More
